13D Management’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-266,900
Closed -$3.97M 29
2022
Q4
$3.97M Sell
266,900
-26,441
-9% -$431K 2.09% 27
2022
Q3
$4.84M Hold
293,341
2.53% 21
2022
Q2
$6.16M Buy
293,341
+18,232
+7% +$372K 2.73% 21
2022
Q1
$6.46M Sell
275,109
-24,306
-8% -$595K 2.46% 26
2021
Q4
$8.15M Sell
299,415
-18,354
-6% -$491K 3.12% 16
2021
Q3
$9.03M Hold
317,769
3.36% 12
2021
Q2
$9.58M Sell
317,769
-3,757
-1% -$111K 3.3% 15
2021
Q1
$8.19M Buy
321,526
+5,660
+2% +$145K 3.03% 20
2020
Q4
$7.75M Sell
315,866
-207,465
-40% -$3.9M 3.2% 17
2020
Q3
$8.52M Buy
523,331
+10,814
+2% +$201K 3.75% 13
2020
Q2
$8.76M Sell
512,517
-21,152
-4% -$314K 3.81% 13
2020
Q1
$6.21M Buy
+533,669
New +$11M 3.02% 20
2018
Q3
Sell
-180,713
Closed -$7.82M 34
2018
Q2
$7.82M Sell
180,713
-120,000
-40% -$5.75M 1.99% 30
2018
Q1
$16.7M Buy
300,713
+85,713
+40% +$4.7M 4.64% 4
2017
Q4
$11.5M Buy
+215,000
New +$10.1M 3.42% 15

Other funds holding MD

13D Management's MD Position: Q1 2023 in Review

13D Management sold out of Pediatrix Medical (MD) in Q1 2023, closing a stake of 266,900 shares — an estimated $3.97M sold.

13D Management first reported a position in MD in Q4 2017 and held it in 15 quarters. The position peaked at $16.7M in Q1 2018. 214 funds tracked by Wall St. Rank hold MD as of Q1 2023.

  • 13D Management reported no remaining Pediatrix Medical position as of Q1 2023 after selling out during the quarter.
  • 13D Management sold 266,900 Pediatrix Medical shares in Q1 2023, an estimated $3.97M.
  • 13D Management first reported a position in Pediatrix Medical in Q4 2017 and held it in 15 quarters.
  • 13D Management's Pediatrix Medical position peaked at $16.7M in Q1 2018.
  • 214 funds tracked by Wall St. Rank held Pediatrix Medical as of Q1 2023.

Based on 13D Management's 13F filing for Q1 2023, filed 15 May 2023.